Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 31, 2015 1:07 AM ET

Biotechnology

Company Overview of Idenix Pharmaceuticals Inc.

Executive Profile

Douglas L. Mayers M.D.

Chief Medical Officer and Executive Vice President of Clinical Development, Idenix Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 1 different industries.

61$846,701
As of Fiscal Year 2013

Background

Dr. Douglas Mayers, also known as Doug, M.D., has been the Chief Medical Officer and Executive Vice President of Clinical Development at Idenix Pharmaceuticals Inc. since January 2007. Dr. Mayers is responsible for Idenix Pharmaceuticals Inc.'s clinical development activities. He remains in the Navy Reserves and serves as Captain. Prior to Idenix Pharmaceuticals Inc., Dr. Mayers served as International Head and Vice President of Therapeutic Area of Virology with Boehringer ...

Corporate Headquarters

320 Bent Street
Cambridge, Massachusetts 02141

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
The University of Pennsylvania

Other Affiliations

Annual Compensation

Salary$376,923
Total Annual Compensation$376,923

Stocks Options

All Other Compensation$6,902
Exercisable Options$430,313
Exercisable Options Value$505,397
Unexercisable Options$174,687
Unexercisable Options Value$171,203
Total Value of Options$676,600
Total Number of Options$605,000

Total Compensation

Total Annual Cash Compensation$482,825
Total Short Term Compensation$376,923
Other Long Term Compensation$6,902
Total Calculated Compensation$846,701
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Idenix Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.